| Literature DB >> 25282142 |
Yu-Dong Xu, Yu Wang, Gyoung-Hee Park, Lei-Miao Yin, Jun Ran, Yan-Yan Liu, Yong-Qing Yang1.
Abstract
BACKGROUND: The total effects of adequate real acupuncture treatment consist of pathologic-specific and non-specific physiological effects. The latter may be the fundamental component of the therapeutic effects of acupuncture. This study investigated the physiological background effects of acupuncture in normal rats treated with acupuncture.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25282142 PMCID: PMC4192787 DOI: 10.1186/1472-6882-14-375
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Figure 1Rats on the suspended shelf. For the convenient manipulation of the acupuncture points on the back, rats were placed on the suspended shelf (50 × 45 mm, approximately 50 cm high from the ground), which calmed the rats and allowed them to stand still without anesthesia.
The 25 differentially expressed proteins between NC and NA rats
| Spot No. | Protein name | Gene symbol | Swiss-prot No. | Theoretical Mr (kDa)/PI | Pept./Cov% a) | Fold change b) |
|---|---|---|---|---|---|---|
| 1 | Alpha-1-antiproteinase | Serpina1 | P17475 | 46.1/5.7 | 6/11.68% | ↓2.62 |
| 2 | Gama-enolase | Eno2 | P07323 | 47.0/7.0 | 2/5.07% | ↓3.2 |
| 3 | Calreticulin | Calr | P18418 | 48.0/4.3 | 49/36.06% | ↓5.78 |
| 4 | Phosphatidylethanolamine-binding protein 1 | Pebp1 | P31044 | 20.8/5.5 | 9/25.13% | ↓2.51 |
| 5 | Actin, alpha skeletal muscle | Acta1 | P68136 | 42.0/5.2 | 29/22.02% | ↓2.49 |
| 6 | Actin, cytoplasmic 1 | Actb | P60711 | 41.7/5.3 | 13/10.67% | ↑4.17 |
| 7 | Beta-enolase | Eno3 | P15429 | 47.0/7.0 | 2/5.07% | ↓3.29 |
| 8 | Creatine kinase B-type | Ckb | P07335 | 42.7/5.4 | 2/4.46% | ↑3.18 |
| 9 | Actin, alpha skeletal muscle | Acta1 | P68136 | 42.0/5.2 | 8/11.94% | ↑4.58 |
| 10 | serum albumin precursor | Alb | P02770 | 68.7/6.0 | 7/6.58% | ++ |
| 11 | Heat shock cognate 71 kDa protein | Hspa8 | P63018 | 70.9/5.4 | 35/30.03% | ↑2.26 |
| 12 | Transgelin 2 | Tagln2 | Q5XFX0 | 23.4/7.6 | 15/32.38% | ++ |
| 13 | Creatine kinase B-type | Ckb | P07335 | 42.7/5.4 | 2/4.46% | ↑2.27 |
| 14 | Fibrinogen beta chain | Fgb | P14480 | 54.2/7.9 | 55/45.3% | -- |
| 15 | Heat shock cognate 71 kDa protein | Hspa8 | P63018 | 70.9/5.4 | 19/18.89% | ↑3.16 |
| 16 | Glyceraldehyde-3-phosphate dehydrogenase | Gapdh | P04797 | 35.8/8.1 | 20/20.12% | ↑3.36 |
| 17 | 22 kDa protein | — | — | 21.9/9.8 | 7/25.00% | ↑2.21 |
| 18 | Heterogeneous nuclear ribonucleoproteins A2/B1 | Hnrnpa2b1 | A7VJC2 | 37.4/9.0 | 46/36.83% | ↑3.1 |
| 19 | Tubulin alpha-1A chain | Tuba1a | P68370 | 50.1/4.9 | 2/5.32% | ↓17.16 |
| 20 | Phosphoglycerate mutase 1 | Pgam1 | P25113 | 28.8/6.7 | 11/16.93% | -- |
| 21 | Serum albumin precursor | Alb | P02770 | 68.7/6.0 | 39/30.59% | ↑2.5 |
| 22 | NG,NG-dimethylarginine dimethylaminohydrolase 2 | Ddah2 | Q6MG60 | 29.7/5.7 | 6/11.93% | ++ |
| 23 | Annexin A5 | Anxa5 | P14668 | 35.7/4.9 | 14/23.20% | ++ |
| 24 | Advanced glycosylation end product-specific receptor | Ager | Q63495 | 42.7/5.8 | 7/8.21% | ↑2.37 |
| 25 | Peroxiredoxin-6 | Prdx6 | O35244 | 24.8/5.6 | 13/26.34% | -- |
a)The number of matching peptides (Pept.) and percentage of the total amino acid sequence covered by the peptides (% Seq. Cov) from the mass mapping experiments.
b)The change level in optical density of the protein spots in NA rats compared with NC rats.
c)++ represents spots detected in gels from the NA samples but not detected in NC samples, which was considered up-regulated in the NA group.
d)-- represents spot detected in gels from the NC samples but not detected in NA samples, which was considered down-regulated in the NA group.
Figure 2The identified proteins were analyzed according to Gene Ontology (GO) enrichment using WebGestalt (WEB-based GEne SeT AnaLysis Toolkit). (A) Directed Acyclic Graph (DAG) of the enriched GO categories under Biological Process. Each node shows the name of the GO category, the number of gene/proteins in the category and the P value indicating the significance of enrichment. (B) and (C) GO classification from the Biological Process and Molecular Function ontology enrichment. The number of proteins enriched in each GO term is shown at the right side of the bars.
List of enriched KEGG pathways of the differentially expressed proteins
| KEGG pathway | Hits number | Corresponding gene symbol | Statistics for the enrichment of the pathway |
|---|---|---|---|
| Glycolysis/Gluconeogenesis | 4 | Eno3, Eno2, Gapdh, Pgam1 | C = 78; R = 115.29; adjP = 2.78e-07 |
| Metabolic pathways | 6 | Eno3, Eno2, Gapdh, Pgam1, Prdx6, Ckb | C = 1169; R = 11.54; adjP = 3.02e-05 |
| Phagosome | 3 | Tuba1a, Actb, Calr | C = 185; R = 36.46; adjP = 0.0002 |
| RNA degradation | 2 | Eno3, Eno2 | C = 77; R = 58.40; adjP = 0.0007 |
| Complement and coagulation cascades | 2 | Fgb, Serpina1 | C = 69; R = 65.17; adjP = 0.0007 |
| Protein processing in endoplasmic reticulum | 2 | Hspa8, Calr | C = 164; R = 27.42; adjP = 0.0024 |